Researchers at UCLA’s Jonsson Comprehensive Cancer Center have developed a gene-based imaging system to target castration resistant prostate cancers (CRPCs), potentially allowing oncologists to find and treat metastases faster.
18F-FDG uptake values measured by positron emission mammography (PEM) correlated with prognostic indicators that predict breast cancer survival and inform clinical management, including receptor status, tumor histology and tumor grade, according to a study published in the August issue of
American Journal of Roentgenology.
Molecular theranostics holds promise, offered a review published in the August issue of American Journal of Roentgenology.
Direct communication of imaging results by radiologists to patients has bubbled to the surface in the last few years. It’s fueled by patient demands for expediency, healthcare reform and the role of miscommunication in malpractice suits. Proposed, but stalled, legislation in Pennsylvania—the Patient Test Result Information Act—would have required radiology facilities to send exam results to patients.
The National Comprehensive Cancer Network (NCCN) has established a new initiative, the NCCN Specialized Imaging Research Consortium, designed to advance the treatment of patients with cancer through the clinical application of specialized imaging technologies.
